Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Title Grant Type Focus Area Country Application Due Date Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Quality Improvement in Pediatric Endocrinology fieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan Topical Hemostasis in Minimally Invasive SurgeryRelease Date:Education Hospital USA Advances in Immuno-Oncology Therapy in Urothelial CancerRelease Date:Education Oncology Japan IBD Fellow Training in USRelease Date:Education Inflammation & Immunology USA Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal CancerQuality Improvement Oncology USA Imaging Diagnostics for Differentiating Cardiac AmyloidosisRelease Date:Education Rare Disease Japan Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown CauseRelease Date:Education Rare Disease Japan Improving Treatment Environment for Chronic Myeloid Leukemia (CML)Release Date:Education Oncology Japan Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and CaregiversRelease Date:Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom Atrial Fibrillation and Venous Thromboembolism (excluding United States)Education Internal Medicine All China Breast Cancer Landscape – Educational Needs AssessmentRelease Date:Education Oncology China